This website is intended for healthcare professionals

Side effects of decongestants in cold and flu season

As we make our way through cold and flu season, prescribers are likely to encounter many patients with varying degrees of illness from these viruses..

Prescribing in the homeless population

This article, published in the International Journal of Clinical Pharmacy aimed to investigate the prescribing of medicines to homeless persons who present to specialist homelessness primary care...

Motor neurone disease

The recent death from motor neurone disease (MND) of former Scottish rugby international and British Lion Doddie Weir OBE (1970–2022) has renewed focus on this neurodegenerative condition.

Non-medical prescribing in primary care in the UK: an overview of the current literature

Non-medical prescribing is increasingly being recognised as an essential healthcare practice, with at least 18 countries adopting NMP across Europe, the Americas and Australasia (Courtenay et al,...

Breastfeeding and medication for long-term conditions

When prescribing to breastfeeding women we need to be aware that some of the drug which she takes is likely to pass to the baby via breastmilk. The British National Formulary (BNF) is not always a...

Is vitamin D supplementation of potential benefit for community-living people with Alzheimer's disease?

Increased age may result in significant changes, such as the accumulation of harmful substances and the lack of essential vitamins and minerals in the body (Fusco et al, 2007; Rahal et al, 2014)....

Strike action looms as we enter 2023

Hello and happy New Year from the Journal of Prescribing Practice. As always, when writing a new year editorial, it's important to look to the year ahead and envision what we might encounter. While...

Updates

Following the announcement of serious shortage protocols (SSPs) on Thursday, December 15, five new SSPs have been issued..

Drug Breakdown: Celecoxib

Day 1: The discovery of the COX-2 channel in the early 1990s led to two new NSAIDs designed and licensed with COX-2 selective action. The new drug target implied therapeutic and adverse drug effect...

Updates

The batches shown in Table 1 of Targocid 200 mg powder for injection/infusion or oral solution are being recalled immediately by Sanofi UK. This is due to out of specification results for bacterial...

The question of social prescribing

A new review, published in the BMJ Open (Kiely et al, 2022), found that there is no consistent evidence that social prescribing improves social support or physical function, or reduced the use of...

Daptomycin

Day 1: #daptomycin was discovered in the late 1980s, when Streptomyces roseoporus bacteria was isolated from a Turkish soil sample. Adverse effects led to delays in clinical trials...

Why choose Journal of Prescribing Practice?

Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.

What's included

  • Evidence-based best practice

  • Drug updates

  • Pharmacology information

  • Calculation skills

Subscriptions start:

From £16.25 GBP